Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies [Phase 1]
A Phase 1 trial evaluating gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced solid tumors, including b…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating green tea extract in nonmetastatic bladder cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin [Phase 2]
Phase 2 neoadjuvant gemcitabine plus weekly cisplatin for muscle-invasive bladder cancer (including patients not candidates for high-dose ci…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer [Phase 2]
A Phase II study of Genistein (Isoflavone G-2535) in bladder cancer has completed and results were posted in 2016.
-
CLINICAL_TRIALS research · 2016-03-24Clinical Trial Update: Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer [NA]
A clinical trial update describes a study of transurethral resection of bladder tumor followed by adjuvant intravenous gemcitabine/cisplatin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer [Phase 2]
A Phase 2 clinical trial combining cisplatin, gemcitabine, and bevacizumab for metastatic bladder cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
This completed clinical trial from Herlev Hospital examines sexual function in patients suspected of non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 neoadjuvant chemotherapy trial evaluating gemcitabine, cisplatin, and sunitinib (GC-S) for muscle-invasive bladder cancer; study com…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract [Phase 2]
Phase 2 SWOG trial of gemcitabine and paclitaxel in advanced or recurrent urinary tract cancers (bladder cancer, transitional cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Cone Beam CT Scanning in Lung and Bladder Cancer.
Clinical trial update indicating the Cone Beam CT scanning study in lung and bladder cancer has completed. The update does not provide trial…
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: CIK in Treating Patients With Bladder Cancer [Phase 2]
An update on a Phase 2 trial of cytokine-induced killer (CIK) cell therapy for bladder cancer, with the study listed as active but not curre…
-
FDA approval · 2016-01-26FDA Approved: GEMCITABINE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' supplemental application for gemcitabine hydrochloride (gemcitabine), enabling continued producti…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium [Phase 2]
This updates the completion of a Phase 2 trial of sunitinib in patients with progressive metastatic urothelial cancer (transitional cell car…
-
CLINICAL_TRIALS research · 2016-01-21Clinical Trial Update: Laser Treatment of Bladder Tumors in the Outpatient Department [NA]
A clinical trial update describes laser treatment of bladder cancer in an outpatient setting; phase and status information are not provided.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]
Phase 1 safety study of an antisense product in multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes [NA]
A completed clinical trial evaluated SVV-guided fluid therapy during bladder cancer surgery. It examined whether this approach reduces intra…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Comparison of White Light, PDD and NBI in Detection of Flat Dysplasia and CIS at TURB - a Study of Trimodality
A study comparing White Light cystoscopy, fluorescence PDD, and Narrow Band Imaging for detecting flat dysplasia and carcinoma in situ durin…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma [Phase 2]
Amrubicin was tested as a second-line therapy in advanced/metastatic refractory urothelial carcinoma in a Phase 2 trial; the study was termi…
-
CLINICAL_TRIALS research · 2015-12-18Clinical Trial Update: Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
A completed feasibility study evaluating the use of MRI and PET imaging for the diagnosis and staging of bladder cancer, with no treatment d…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
A completed study investigating whether genetic factors influence recurrence and progression in non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Use of Multiphoton Microscopy in the Diagnosis of Cancer [Phase 1]
Phase 1 trial evaluating multiphoton microscopy for diagnosing bladder and prostate cancer, completed.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy [Phase 2, Phase 3]
A completed Phase 2/3 randomized trial in advanced bladder cancer comparing first-line gemcitabine with versus without vinflunine in patient…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer [NA]
This is a completed pilot trial evaluating Lipiodol for demarcating bladder tumors in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer [Phase 1]
Phase I trial evaluating mitomycin C combined with BCG for bladder cancer has completed.
-
CLINICAL_TRIALS research · 2015-11-10Clinical Trial Update: Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery [NA]
This clinical trial update examines how different pressures used during robot-assisted surgery affect myocardial and pulmonary injuries, in …